Your web browser does not support JavaScript, but it does not affect browsing through the rest of the web site. Go to Main Content

Targeted Drug Development

:::

Targeted Drug Development

Application and Product

Protein Drug

  • Novel Collagen Scaffold Antibodies for the Treatment of Autoimmune Diseases and Solid Tumor 

Small-Molecule Drug

  • ITRI-260 – a Drug Candidate for Acute Myeloid Leukemia
  • Liposomal Endorphin for Pain Treatment
  • Anti-brain Tumor New Drug using Cross-Blood-Brain Barrier DDS
  • Neurologic New Drug Development (for Alzheimer's disease, Parkinson's disease, Schizophrenia) using Sustained Release DDS (PLGA microsphere formulation)
  • Anti-colon Cancer Drug using Nanopolymeric Micelle Formulation
  • Oral Delivery Formulation on Calcitonin and Insulin
  • The Development and Pilot Manufacture of New CINV Transdermal Patch
  • Anti-acne Liposomal Gel 

Herbal Medicine

  • Anti-hepatitis C Composition and Method of Preparation
  • A Botanical Immune Modulator and Method of Preparation
  • A Composition for Decreasing Ethanol Concentration in Blood After Consuming Alcohols
  • Production of Bupleurum Polysaccharides from Plant Cell Culture 

Others

  • Customized LIMS (Laboratory Information Management System) and GxP Management System


Contact

Biomedical Technology and Device Research Laboratories

Email: ITRI_BDL@itri.org.tw

  

More Information